Conference Coverage

End-stage renal disease risk in lupus nephritis remains unchanged of late


 

FROM ARTHRITIS & RHEUMATOLOGY

References

The study was supported by the intramural research program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The authors reported having no conflicts of interest.

pwendling@frontlinemedcom.com

Pages

Recommended Reading

Second dose of herpes zoster vaccine beneficial to seniors
MDedge Rheumatology
Rheumatology trends, research, concerns highlighted for 2016
MDedge Rheumatology
FDA approves selexipag for pulmonary arterial hypertension
MDedge Rheumatology
EADV: Fresolimumab shows early promise in scleroderma
MDedge Rheumatology
ACR: Actual-weight hydroxychloroquine dosing works in SLE, up to a point
MDedge Rheumatology
ACR: VEBs predict sudden cardiac death in systemic sclerosis
MDedge Rheumatology
ACR: First U.S. clinical practice guidelines arise for Sjögren’s syndrome management
MDedge Rheumatology
EADV: DLX105 is a novel treatment strategy for Behçet’s flares
MDedge Rheumatology
Biologic treatment in pregnancy requires balancing risks
MDedge Rheumatology
Axis I psychiatric disorders high in skin-restricted lupus patients
MDedge Rheumatology